Skip to main content
Fig. 3 | BMC Urology

Fig. 3

From: A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain

Fig. 3

Persistence with mirabegron compared with individual antimuscarinics: subgroup analysis. *Reference comparator; †Not evaluated due to small sample size; ‡HRs, 95% CI and p-values generated using a Cox regression model with adjustment for age and treatment status. CI, confidence intervals; HR, hazard ratio; NR, not reached; OAB, overactive bladder; TTD, time to discontinuation

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us